Affiliation:
1. Clinic and Research Center of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China
2. Department of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200092, China
3. Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200092, China
Abstract
The non-tuberculous mycobacterium (NTM) is a very troublesome opportunistic pathogen, placing a heavy burden on public health. The pathogenesis of NTM pulmonary infection is not well-revealed yet, and its diagnosis is always challenging. This study aimed to use a comprehensive proteomics analysis of plasma exosomes to distinguish patients with rapidly growing NTM M. abscessus (MAB), slowly growing NTM M. intracellulare (MAC), and Mycobacterium tuberculosis (MTB). The identified protein components were quantified with label-free proteomics and determined with a bioinformatics analysis. The complement and coagulation were significantly enriched in patients with Mycobacterium infection, and a total of 24 proteins were observed with up-regulation, which included C1R, C1S, C2, MASP2, C4B, C8B, C9, etc. Of them, 18 proteins were significantly up-regulated in patients with MAB, while 6 and 10 were up-regulated in patients with MAC or MTB, respectively. Moreover, MAB infection was also related to the HIF-1 signaling pathway and phagosome processes, and MTB infection was associated with the p53 signaling pathway. This study provided a comprehensive description of the exosome proteome in the plasma of patients infected with MAB, MAC, and MTB and revealed potential diagnostic and differential diagnostic markers.
Funder
Shanghai Clinical Research Center for infectious disease
Subject
Virology,Microbiology (medical),Microbiology
Reference31 articles.
1. Update on pulmonary disease due to non-tuberculous mycobacteria;Stout;Int. J. Infect. Dis.,2016
2. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: A review;Prevots;Clin. Chest Med.,2015
3. Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS/ERS/ESCMID/IDSA clinical practice guideline;Daley;Eur. Respir. J.,2020
4. Nontuberculous mycobacterium: An emerging pathogen: Indian perspective;Rajendran;Int. J. Mycobacteriol.,2021
5. Exosome-Induced Regulation in Inflammatory Bowel Disease;Zhang;Front. Immunol.,2019